Ezetimibe and atherosclerotic cardiovascular disease: a systematic review and meta-analysis

Ezetimibe and atherosclerotic cardiovascular disease: a systematic review and meta-analysis

IntroductionIndividuals diagnosed with atherosclerotic cardiovascular disease (ACD) are exposed to an increased risk of cardiovascular events. Reducing low-density lipoprotein cholesterol (LDL-C) levels has been established as an effective approach to mitigate these risks. However, a comprehensive a...

Full description

Bibliographic Details
Main Authors: Fatemeh Omidi, Maryam Rahmannia, Amir Hashem Shahidi Bonjar, Parsa Mohammadsharifi, Mohammad Javad Nasiri, Tala Sarmastzadeh
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
low-density lipoprotein cholesterol
ezetimibe
systematic review
cardiovascular disease
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1269172/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1269172/full

Similar Items